Caxton Associates (New York)’s National Vision EYE Stock Holding History
Bought
Maintained
Sold
Other funds holding EYE
KKRC
TCM
Caxton Associates (New York)'s EYE Position: Q2 2019 in Review
Caxton Associates (New York) sold out of National Vision (EYE) in Q2 2019, closing a stake of 12,495 shares — an estimated $393K sold.
Caxton Associates (New York) first reported a position in EYE in Q1 2019 and held it in 1 quarter. The position peaked at $393K in Q1 2019. 163 funds tracked by Wall St. Rank hold EYE as of Q2 2019.
- Caxton Associates (New York) reported no remaining National Vision position as of Q2 2019 after selling out during the quarter.
- Caxton Associates (New York) sold 12,495 National Vision shares in Q2 2019, an estimated $393K.
- Caxton Associates (New York) first reported a position in National Vision in Q1 2019 and held it in 1 quarter.
- Caxton Associates (New York)'s National Vision position peaked at $393K in Q1 2019.
- 163 funds tracked by Wall St. Rank held National Vision as of Q2 2019.
Based on Caxton Associates (New York)'s 13F filing for Q2 2019, filed 14 Aug 2019.